Jiangsu Recbio Technology Co., Ltd. (stock code: 2179) announced that it received listing approval from The Stock Exchange of Hong Kong Limited on February 5, 2026 for converting 141,953,489 unlisted shares into H shares. This development follows the earlier disclosures on May 21, 2025 and January 30, 2026 regarding the proposed participation in H Share Full Circulation.

A total of 28 shareholders participate in the conversion, covering 141,953,489 shares. Following completion of the conversion and listing procedures, Jiangsu Recbio’s overall share count remains 626,075,702 shares. The proportion of domestic shares decreases from 47.59% to 26.83%, while the portion of H shares rises from 50.50% to 73.17%.

Jiangsu Recbio will proceed with the relevant conversion and trading procedures for the newly converted H shares. Market participants are advised to monitor official company announcements for developments regarding the timeline and completion of the listing process.